Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse NT-4 ELISA Kit (AC2655)
Cat.#: ASET-1244
Specifications
Description Mouse NT-4 ELISA Kit allows for the in vitro quantitative determination of mouse NT-4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1254 Human SHP2 ELISA Kit (AC2665) Quantitative inquiry ASET-1929 Human APH1A ELISA Kit (AC3340) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry ASET-1679 Human Synaptogyrin 3 ELISA Kit (AC3090) Quantitative inquiry ASET-1117 Mouse ADAM17 ELISA Kit (AC2528) Quantitative inquiry ASET-1431 Human Kallikrein 6 ELISA Kit (AC2842) Quantitative inquiry ASET-2310 Human C1QB ELISA Kit (AC3721) Quantitative inquiry ASET-2211 Mouse Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3622) Quantitative inquiry ASET-1442 Porcine Leptin ELISA Kit (AC2853) Quantitative inquiry ASET-2002 Human 160 kD Neurofilament Medium ELISA Kit (AC3413) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket